Synaptogenix to Present at Hanson Wade 10th Annual Neurodege

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

Related Keywords

, Daniel Alkon , Hanson Wade , Robert Weinstein , Exchange Commission , National Institute Of Health , Drug Administration , Neurodegenerative Drug Development Summit On , Neurodegenerative Drug Development Summit , Nasdaq , Synaptogenix Inc , Chief Scientific Officer , Annual Neurodegenerative Drug Development Summit , Targets Restoration , Synaptic Wiring , Advanced Alzheimer , National Institute , Annual Neurodegenerative Drug Development , Orphan Drug Designation , Synaptogenix , Nc , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Pharmaceuticals , Trade Show News ,